Topical azithromycin or ofloxacin for endophthalmitis prophylaxis after intravitreal injection.

Clin Ophthalmol 2012 9;6:1595-9. Epub 2012 Oct 9.

Department of Ophthalmology, Hospital Universitari Sant Joan, Universidad Rovira i Virgili, Reus.

Background: The number of patients who have undergone intravitreal injections has increased enormously in recent years, but a consensus is still lacking on prophylaxis for endophthalmitis. The aim of this prospective, observational study was to evaluate the prophylactic effect of azithromycin eye drops versus ofloxacin eye drops.

Methods: The study was conducted in five hospitals in Spain and included all patients undergoing intravitreal injections of triamcinolone, bevacizumab, ranibizumab, or pegaptanib over one year. Patients received azithromycin 15 mg/g eye drops (twice daily on the day prior to injection and for another 2 days) or ofloxacin 3 mg/g eye drops (every 6 hours on the day prior to injection and for another 7 days).

Results: In the azithromycin group, there were 4045 injections in 972 eyes of 701 patients. In the ofloxacin group, there were 4151 injections in 944 eyes of 682 patients. There were two cases of endophthalmitis (0.049%) in the azithromycin group and five (0.12%) in the ofloxacin group. The odds ratio of presenting with endophthalmitis in the ofloxacin group compared with the azithromycin group was 2.37 (95% confidence interval [CI] 1.32-3.72, P < 0.001). There were two cases of noninfectious uveitis after triamcinolone injection in the azithromycin group (0.049%) and two (0.048%) in the ofloxacin group; no significant differences were observed (odds ratio 0.902, 95% CI 0.622-1.407, P = 0.407). Conjunctival hyperemia was observed in 12 cases in the azithromycin group and none in the ofloxacin group.

Conclusion: The risk of endophthalmitis was significantly greater with ofloxacin than with azithromycin. These findings provide a valuable addition to the ever-increasing pool of information on endophthalmitis prophylaxis after intravitreal injection, although further large-scale studies are required to provide definitive conclusions.

Download full-text PDF

Source
https://pdfs.semanticscholar.org/4456/30870400aaf141a14cb736
Web Search
http://www.dovepress.com/topical-azithromycin-or-ofloxacin-f
Publisher Site
http://dx.doi.org/10.2147/OPTH.S35795DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474266PMC
October 2012

Publication Analysis

Top Keywords

azithromycin group
20
ofloxacin group
16
eye drops
12
ofloxacin
9
group
9
odds ratio
8
intravitreal injections
8
prior injection
8
day prior
8
intravitreal injection
8
mg/g eye
8
azithromycin
8
prophylaxis intravitreal
8
endophthalmitis prophylaxis
8
endophthalmitis
6
injection
5
patients
5
injection daysresults
4
drops hours
4
hours day
4

Similar Publications